Randomized Clinical Trial Comparing 5% and 1% Topical Minoxidil for the Treatment of Androgenetic Alopecia in Japanese Men

    July 2009 in “ Journal of Dermatology
    Ryoji Tsuboi, Osamu Arano, Tooru Nishikawa, Hidekazu Yamada, Kensei Katsuoka
    Image of study
    TLDR 5% minoxidil works better for hair growth than 1% minoxidil.
    This study compared the effectiveness of 5% and 1% topical minoxidil for treating androgenetic alopecia in Japanese men. The trial included 300 male patients who were administered either 5% or 1% topical minoxidil for 24 weeks. The study found that 5% topical minoxidil was more effective than 1% topical minoxidil in promoting hair growth, as measured by hair count, investigators' assessment, and patients' impression of hair growth. The incidence of adverse events was similar between the two groups, with dermatological adverse events being more common in the 5% topical minoxidil group. Overall, the study demonstrated that 5% topical minoxidil is more efficacious in treating androgenetic alopecia in men than 1% topical minoxidil.
    Discuss this study in the Community →

    Research cited in this study

    19 / 19 results

    Related Community Posts Join

    6 / 1000+ results

      community What else is good. Besides the big 3.

      in Chat  34 upvotes 2 months ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    7 / 7 results